NattoPharma ASA is launching cash tender offer to acquire 100% of the shares of Kaydence Pharma AS at an offer price of NOK 5 per share
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.Oslo, Norway (9 March 2021) — Reference is made to the stock exchange disclosures by NattoPharma ASA ("NattoPharma") on 15 February 2021 regarding NattoPharma entering into a transaction agreement (the "Transaction Agreement") with Compagnie des Levures Lesaffre ("Lesaffre") under which (i) Lesaffre will launch a recommended voluntary cash tender offer (the "NattoPharma Offer") to acquire 100% of the shares of